Call Options

14 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$64.0 - $116.06 $10.6 Million - $19.2 Million
165,300 Added 158.18%
269,800 $18.1 Million
Q2 2024

Aug 12, 2024

BUY
$110.31 - $140.45 $4.47 Million - $5.69 Million
40,500 Added 63.28%
104,500 $11.8 Million
Q1 2024

May 15, 2024

SELL
$114.22 - $140.1 $2.84 Million - $3.49 Million
-24,900 Reduced 28.01%
64,000 $8.88 Million
Q4 2023

Feb 12, 2024

SELL
$75.49 - $124.16 $3.1 Million - $5.09 Million
-41,000 Reduced 31.56%
88,900 $11 Million
Q3 2023

Nov 13, 2023

BUY
$86.06 - $137.93 $6.27 Million - $10 Million
72,800 Added 127.5%
129,900 $12.1 Million
Q2 2023

Aug 11, 2023

BUY
$112.47 - $130.98 $416,139 - $484,625
3,700 Added 6.93%
57,100 $7.34 Million
Q1 2023

May 15, 2023

BUY
$104.0 - $122.92 $280,800 - $331,884
2,700 Added 5.33%
53,400 $6.2 Million
Q4 2022

Feb 14, 2023

BUY
$84.98 - $122.67 $1.78 Million - $2.56 Million
20,900 Added 70.13%
50,700 $5.74 Million
Q3 2022

Nov 14, 2022

BUY
$76.35 - $94.18 $748,230 - $922,964
9,800 Added 49.0%
29,800 $2.42 Million
Q2 2022

Aug 11, 2022

BUY
$67.99 - $132.89 $1.23 Million - $2.41 Million
18,100 Added 952.63%
20,000 $1.5 Million
Q3 2021

Nov 12, 2021

BUY
$106.71 - $143.18 $21,342 - $28,636
200 Added 11.76%
1,900 $1.04 Million
Q2 2021

Aug 13, 2021

BUY
$80.99 - $107.93 $56,693 - $75,551
700 Added 70.0%
1,700 $181,000
Q2 2020

Aug 14, 2020

SELL
$62.68 - $105.34 $25,072 - $42,136
-400 Reduced 28.57%
1,000 $405,000
Q1 2019

May 15, 2019

BUY
$28.07 - $38.18 $39,298 - $53,452
1,400 New
1,400 $167,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.